CDC adds almost 100 new cases to expanding US measles outbreak
On Aug. 7, 2026, The Centers for Disease Control and Prevention (CDC) confirmed 94 new measles infections—most of…
On Aug. 7, 2026, The Centers for Disease Control and Prevention (CDC) confirmed 94 new measles infections—most of…
On Jul. 27, 2026, Michigan health officials reported 9,253 cases of cyclosporiasis, an increase of 1,077 cases since…
On Jul. 24, 2026, the number of measles cases in the U.S. surpassed the record-breaking tally for all…
On Jul. 24, 2026, The U.S. Centers for Disease Control and Prevention has linked four additional states to…
On Jul. 22, 2026, The U.S. Food and Drug Administration (FDA) announced it is investigating a new outbreak…
On Jun. 19, 2026, the International Atomic Energy Agency (IAEA) and Food and Agriculture Organization of the United…
On Sept. 21, 2025, Mexico’s National Service of Agro-Alimentary Health, Safety, and Quality (SENASICA) confirmed a new case…
On Aug. 27, 2025, Mexico has recorded 5,086 cases of flesh-eating screwworm in animals as of August 17,…
On Jun. 30, 2025, the U.S. Department of Agriculture (USDA) announced risk-based port re-openings for cattle, bison, and…
On Jun. 18, 2025, the U.S. Department of Agriculture announced it has launched an $8.5 million sterile New…
On Apr. 7, 2025, the Colorado Department of Public Health and Environment issued a Health Alert Network (HAN)…
On Apr. 4, 2025, a 3-year-old girl from the western state of Durango is Mexico’s first confirmed human…
On Apr. 2, 2025, the Colorado Department of Public Health and Environment issued a Health Alert Network (HAN)…
On Jun. 5, 2024, the World Health Organization (WHO) reported that a person with prior health complications who…
On Oct. 18, 2023, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
On May 2, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
On Apr. 7, 2023, the U.S. National Park Service reported Highly Pathogenic Avian Influenza (HPAI) had been confirmed…
On May 2, 2022, Sorrento announced its Phase I study of intranasal STI-919 OVISHIELDTM) had been fully enrolled…
On Apr. 13, 2022, Novavax announced that Swissmedic had granted Novavax conditional marketing authorization (CMA) for Nuvaxovid COVID-19…
On Mar. 2, 2022, Sorrento Therapeutics announced that its Phase I study of intranasal (IN) STI-9199 (COVISHIELDTM IN) has…
Our Heroes and Remembrance illustration has Maurice Ralph Hilleman and John Enders, pioneering developers of common vaccines, and…
On Nov. 3, 2021, Novavax announced the company had filed for provisional approval of the vaccine to the…
On Nov. 3, 2021, Inovio Pharma announced that it had received authorization from India’s Central Drugs Standard Control…
On Oct. 11, 2021, Inovio Pharmaceuticals announced that it had received authorization from Colombia’s INVIMA, to conduct the…
On Sept. 22, 2021, Inovio Pharmaceuticals announced that it had received authorization from COFEPRIS (Comisión Federal para la…
On Aug. 4, 2021, Novavax announced that it had reached an agreement with the European Commission (EC) for…
On Jun. 14, 2021, Novavax announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against…
On Mar. 24, 2021, scientists from Washington University School of Medicine in St. Louis announced they had identified…
On Oct. 8, 2020, a clinical trial to test the safety, tolerability and efficacy of a combination treatment…
On Sept. 17, 2020, Genentech, a member of the Roche Group announced that the Phase III EMPACTA study…